These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35421639)

  • 61. Associations of upper limb disability measures on different levels of the International Classification of Functioning, Disability and Health in people with multiple sclerosis.
    Lamers I; Cattaneo D; Chen CC; Bertoni R; Van Wijmeersch B; Feys P
    Phys Ther; 2015 Jan; 95(1):65-75. PubMed ID: 25190063
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The multiple sclerosis functional composite: a clinically meaningful measure of disability.
    Polman CH; Rudick RA
    Neurology; 2010 Apr; 74 Suppl 3():S8-15. PubMed ID: 20421572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
    Daams M; Steenwijk MD; Wattjes MP; Geurts JJ; Uitdehaag BM; Tewarie PK; Balk LJ; Pouwels PJ; Killestein J; Barkhof F
    Neurology; 2015 Jul; 85(3):248-55. PubMed ID: 26115736
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of upper extremity function in multiple sclerosis: review and opinion.
    Kraft GH; Amtmann D; Bennett SE; Finlayson M; Sutliff MH; Tullman M; Sidovar M; Rabinowicz AL
    Postgrad Med; 2014 Sep; 126(5):102-8. PubMed ID: 25295653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?
    Lynch S; Baker S; Nashatizadeh M; Thuringer A; Thelen J; Bruce J
    Mult Scler Relat Disord; 2021 Apr; 49():102724. PubMed ID: 33609959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis.
    Koch MW; Mostert J; Repovic P; Bowen JD; Uitdehaag B; Cutter G
    Neurology; 2021 Jan; 96(1):e111-e120. PubMed ID: 33106389
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of health utility measures for the evaluation of multiple sclerosis treatments.
    Fisk JD; Brown MG; Sketris IS; Metz LM; Murray TJ; Stadnyk KJ
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):58-63. PubMed ID: 15607996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
    Behrens J; Pfüller C; Mansow-Model S; Otte K; Paul F; Brandt AU
    J Neuroeng Rehabil; 2014 May; 11():89. PubMed ID: 24886525
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite.
    Costelloe L; O'Rourke K; McGuigan C; Walsh C; Tubridy N; Hutchinson M
    Mult Scler; 2008 Mar; 14(2):255-8. PubMed ID: 17942522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis.
    Shribman S; Hasan H; Hadavi S; Giovannoni G; Noyce AJ
    J Neurol; 2018 Feb; 265(2):285-290. PubMed ID: 29204963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessing upper limb function in multiple sclerosis using an engineered glove.
    Carmisciano L; Signori A; Pardini M; Novi G; Lapucci C; Nesi L; Gallo E; Laroni A; Cellerino M; Meli R; Sbragia E; Filippi L; Uccelli A; Inglese M; Sormani MP
    Eur J Neurol; 2020 Dec; 27(12):2561-2567. PubMed ID: 32805743
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical outcome measures in multiple sclerosis.
    Uitdehaag BM
    Handb Clin Neurol; 2014; 122():393-404. PubMed ID: 24507527
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical scales in progressive MS: predicting long-term disability.
    Bosma LV; Kragt JJ; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Mar; 18(3):345-50. PubMed ID: 21868487
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
    Karabudak R; Dahdaleh M; Aljumah M; Alroughani R; Alsharoqi IA; AlTahan AM; Bohlega SA; Daif A; Deleu D; Amous A; Inshasi JS; Rieckmann P; Sahraian MA; Yamout BI
    Mult Scler Relat Disord; 2015 May; 4(3):192-201. PubMed ID: 26008936
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progressive multiple sclerosis, cognitive function, and quality of life.
    Højsgaard Chow H; Schreiber K; Magyari M; Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Soelberg Sørensen P; Sellebjerg F
    Brain Behav; 2018 Feb; 8(2):e00875. PubMed ID: 29484253
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A cross-sectional comparison of performance, neurophysiological and MRI outcomes of responders and non-responders to fampridine treatment in multiple sclerosis - An explorative study.
    Mamoei S; Jensen HB; Dalgas U; Zijdewind I; Pedersen AK; Nygaard MKE; Eskildsen SF; Stenager E
    J Clin Neurosci; 2020 Dec; 82(Pt A):179-185. PubMed ID: 33317729
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.
    Janardhan V; Bakshi R
    Arch Neurol; 2000 Oct; 57(10):1485-91. PubMed ID: 11030802
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Participation Restriction in People With Multiple Sclerosis: Prevalence and Correlations With Cognitive, Walking, Balance, and Upper Limb Impairments.
    Cattaneo D; Lamers I; Bertoni R; Feys P; Jonsdottir J
    Arch Phys Med Rehabil; 2017 Jul; 98(7):1308-1315. PubMed ID: 28336344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.